A. Morice (Cottingham, United Kingdom), S. Anderson (Camperdown, Australia)
Cough sensitivity to hypertonic saline and dry air hyperventilation are interrelated
M. Purokivi, H. Koskela, K. Kontra (Finland)
|   |
Cough sensitivity, airway responsiveness and exhaled nitric oxide (eNO) for predicting the response to bronchodilator therapy (BDT) in patients with chronic non-productive cough
M. Fujimura, A. Tokuda, N. Ohkura (Kanazawa, Japan)
| |
Cough reflex sensitivity to capsaicin in patients with overlap syndrome
K. Stravinskaite, S. Miliauskas, R. Sakalauskas (Lithuania)
| |
Comparison of FEV1 and PEF values in cough variant asthma during methacholine challenge test
S. Ghodrati, A. Hormati, B. Pezeshki (Zanjan, Islamic Republic Of Iran)
| |
The diagnostic value of bronchial provocation tests in elite athletes
A. Florou, S. Vakali, I. Vogiatzis, M. Vassilopoulou, N. Papadopoulos, C. Gratziou (Athens, Greece)
| |
The maximum % fall in FEV1 after a mannitol challenge in subjects with asthma, suspected asthma, COPD and bronchiectasis
S. D. Anderson, C. P. Perry, H. Fox, B. Charlton (Camperdown, Sydney, Australia)
| |
Exhaled NO, small airway obstruction and airway hyper-responsiveness in pediatric asthma
C. Keen, A. C. Olin, G. Wennergren, P. Gustafsson (Gothenburg, Skövde, Sweden)
| |
Urinary Clara cell protein after eucapnic voluntary hyperpnea and mannitol challenge in athletes
P. Kippelen, E. Tufvesson, L. Ali, L. Bjermer, S. D. Anderson (Uxbridge, Southall, United Kingdom; , Sweden; Camperdown, Australia)
| |
Low FEV1 in obese subjects increases the risk for bronchial hyperresponsiveness
M. Juusela, P. Pallasaho, S. Sarna, A. Sovijärvi (Helsinki, Finland)
| |
Effect of methacholine challenges on exhaled breath temperature measured by a portable handheld device
T. Kralimarkova, T. Grigorova, V. Dimitrov, T. Popov (Bulgaria)
| |
Long term evolution and prognostic factors of bronchial hyperresponsiveness in Greek asthmatics
K. Porpodis, K. Manika, E. Kontakioti, D. Latsios, V. Dimitrakaki, D. Gioulekas, D. Papakosta (Thessaloniki, Greece)
| |
Implication of interleukin-18 in airway remodelling in refractory asthma
N. Rovina, P. Bakakos, G. Hillas, E. Tseliou, E. Dima, C. Roussos, S. Papiris, S. Loukides (Athens, Greece)
| |
ACQ cut-points and asthma control. Measuring Asthma GINA Control. (MAGIC study)
A. M. Fortuna, V. Plaza, J. M. Olaguibel, S. Quirce, J. Molina, B. Juliá (Barcelona, Madrid, Fuenlabrada, Spain)
| |
Association between airway inflammation, disease control and lung function parameters in asthma
Z. Lazar, M. Orosz, G. Galffy, A. Bikov, G. Losonczy, I. Horvath (Budapest, Hungary)
| |
The assessment of exhaled nitric oxide fraction in monitoring asthma control: How to raise the clinical relevance?
V. Tudorache, O. Fira-Mladinescu, C. Babiciu, M. Marc (Timisoara, Romania)
| |
Alveolar nitric oxide is increased in uncontrolled asthma
E. Pozzecco, N. Scichilone, A. Paternò, G. Augugliaro, L. Giuliano, A. Sanfilippo, S. Taormina, M. Marchese, C. Sorino, V. Bellia (Palermo, Italy)
| |
Corticosteroid-induced changes in nasal allergic inflammation are associated with better asthma control
R. Arrigo, S. Impellitteri, N. Scichilone, A. Paternò, R. Santagata, S. Battaglia, F. Braido, I. Baiardini, V. Bellia (Palermo, Genova, Italy)
| |
Predictors of successful oral steroid tapering in severe, prednisone-dependent asthma
S. Hashimoto, P. J. Sterk, E. H. Bel, Monosa Study Group (Amsterdam, Netherlands)
| |